Arvinas (ARVN) Accounts Payables (2017 - 2026)
Arvinas (ARVN) reported Accounts Payables of $52.2 million for Q2 2026, down 1.7% from $53.1 million a year earlier and down 16.2% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Accounts Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas posted Accounts Payables of $69.5 million, down 3.2% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 57.8% (FY2020 to FY2025).
- By year, Accounts Payables came in at $71.8 million in FY2024 (-22.1%), $92.2 million in FY2023 (+23.4%), $74.7 million in FY2022 (+37.3%) and $54.4 million in FY2021 (+666.2%).
- The Q2 2026 figure ranks as the lowest quarterly Accounts Payables since Q3 2022.
- Year over year, Accounts Payables has now declined in each of the last eight quarters, with an average decline of 15.2% over the last eight quarters.
- The high point for year-over-year Accounts Payables in five years was Q3 2022 (growth of 963.9%); the low point was Q2 2025 (a decline of 32.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $62.3 million (Q1 2026), $69.5 million (Q4 2025) and $55.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.64 Bn | 1,139.23 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 647.91 Bn | 567.77 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.02 Bn | 476.13 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.11 Bn | 319.49 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 303.38 Bn | 267.37 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 268.87 Bn | 242.56 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 242.01 Bn | 197.41 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.74 Bn | 168.94 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.37 Bn | 119.01 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Arvinas | 492.16 Mn | -2.16 Bn | - | 52.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.20 Mn |
| Mar 31, 2026 | 62.30 Mn |
| Dec 31, 2025 | 69.50 Mn |
| Sep 30, 2025 | 55.50 Mn |
| Jun 30, 2025 | 53.10 Mn |
| Mar 31, 2025 | 71.10 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 75.90 Mn |
| Jun 30, 2024 | 78.10 Mn |
| Mar 31, 2024 | 76.40 Mn |
| Dec 31, 2023 | 92.20 Mn |
| Sep 30, 2023 | 91.00 Mn |
| Jun 30, 2023 | 74.80 Mn |
| Mar 31, 2023 | 66.00 Mn |
| Dec 31, 2022 | 74.70 Mn |
| Sep 30, 2022 | 49.70 Mn |
| Jun 30, 2022 | 42.10 Mn |
| Mar 31, 2022 | 8.60 Mn |
| Dec 31, 2021 | 54.40 Mn |
| Sep 30, 2021 | 4.67 Mn |
API Access
Arvinas Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();